نتائج البحث - "Jean Tremlett"

المصدر: Lancet (London, England)
FAST-Forward Trial Management Group 2020, ' Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward) : 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial ', Lancet (London, England), vol. 395, no. 10237, pp. 1613-1626 . https://doi.org/10.1016/S0140-6736(20)30932-6

مصطلحات موضوعية: medicine.medical_treatment, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Radiotherapy, Adjuvant/adverse effects, Clinical endpoint, 030212 general & internal medicine, Neoplasm Metastasis, Mastectomy, Neoplasm Recurrence, Local/epidemiology, Aged, 80 and over, Manchester Cancer Research Centre, United Kingdom/epidemiology, Hazard ratio, General Medicine, Middle Aged, Treatment Outcome, Female, Radiation Dose Hypofractionation, Adult, Breast Neoplasms/mortality, Breast Neoplasms, Risk Assessment, Article, 03 medical and health sciences, Breast cancer, medicine, Humans, Risk Assessment/methods, Radiation Injuries, Aged, Neoplasm Staging, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, medicine.disease, R1, United Kingdom, Mastectomy/methods, Radiation therapy, Clinical trial, Regimen, Radiation Injuries/epidemiology, Radiotherapy, Adjuvant, Neoplasm Grading, Neoplasm Recurrence, Local, business, Nuclear medicine, RA, Follow-Up Studies

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e395035946033bfb3c8db03e2d044a

View record from ScienceDirect

Find this article in full text from ProQuest

Full Text via ClinicalKey

6

Randomized Noninferiority Trial of Reduced High-Dose Volume Versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004)

المؤلفون: Isabel Syndikus, Emma Hall, Rebecca Lewis, Fawzi Adab, D. Sheehan, Jean Tremlett, Carey Hendron, Peter Jenkins, Rachel Waters, Christine Rawlings, Syed A. Hussain, Robert Huddart, Malcolm Crundwell, Nicholas D. James

المصدر: International Journal of Radiation Oncology, Biology, Physics

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_treatment, law.invention, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Aged, 80 and over, education.field_of_study, Radiation, Radiotherapy Dosage, Chemoradiotherapy, Middle Aged, Oncology, Radiology Nuclear Medicine and imaging, Carcinoma, Squamous Cell, Female, Fluorouracil, Adult, medicine.medical_specialty, Mitomycin, Urinary Bladder, Population, Urology, Antineoplastic Agents, Adenocarcinoma, Multicenter trial, Confidence Intervals, medicine, Humans, Neoplasm Invasiveness, Radiology, Nuclear Medicine and imaging, Clinical Investigation, Radiation Injuries, education, Aged, Carcinoma, Transitional Cell, Bladder cancer, Intention-to-treat analysis, business.industry, medicine.disease, United Kingdom, Confidence interval, Surgery, Radiation therapy, Clinical trial, Urinary Bladder Neoplasms, Sample Size, Neoplasm Recurrence, Local, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd6092e1d1b0fa9289f170338a425bdc
https://doi.org/10.1016/j.ijrobp.2013.06.2044

View record from ScienceDirect

Full Text via ClinicalKey

7

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

المصدر: Dearnaley, D, Syndikus, I, Mossop, H, Khoo, V, Birtle, A, Bloomfield, D, Graham, J, Kirkbride, P, Logue, J, Malik, Z, Money-Kyrle, J, O'Sullivan, J M, Panades, M, Parker, C, Patterson, H, Scrase, C, Staffurth, J, Stockdale, A, Tremlett, J, Bidmead, M, Mayles, H, Naismith, O, South, C, Gao, A, Cruickshank, C, Hassan, S, Pugh, J, Griffin, C, Hall, E & CHHiP Investigators 2016, ' Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial ', Lancet Oncology, vol. 17, no. 8, pp. 1047–1060 . https://doi.org/10.1016/S1470-2045(16)30102-4
The Lancet. Oncology

مصطلحات موضوعية: Male, medicine.medical_specialty, medicine.medical_treatment, Urology, Androgen suppression, 030218 nuclear medicine & medical imaging, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, SDG 3 - Good Health and Well-being, Risk Factors, law, medicine, Clinical endpoint, Humans, Cumulative incidence, Survival rate, Aged, Neoplasm Staging, Aged, 80 and over, Intention-to-treat analysis, business.industry, International Agencies, Prostatic Neoplasms, Articles, Middle Aged, Survival Rate, Radiation therapy, Clinical trial, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Radiation Dose Hypofractionation, Radiotherapy, Intensity-Modulated, business, Nuclear medicine, Follow-Up Studies